Smith KA

Idioma: Ingles.
Referencias bibliográficas: 24
Paginas: 277-280
Archivo PDF: 110.42 Kb.

FRAGMENTO

Sin resumen.

REFERENCIAS (EN ESTE ARTÍCULO)

1. ACOG Practice Bulletin No. 202: Gestational hypertension and preeclampsia. Obstet Gynecol. 2019;133:211-214.

2. Creanga A. Maternal mortality in the United States: a review of contemporary data and their limitations. Clin Obstet Gynecol. 2018;61:296-306.

3. WHO Department of Reproductive Health and Research. (www.who. int/reproductivehealth).

4. Shields LE, et al. Use of Maternal early warning trigger tool reduces maternal morbidity. Am J Obstet Gynecol. 2016;214:527.e1-527.e6.

5. Gupta M, Greene N, Kilpatrick SJ. Timely treatment of severe maternal hypertension and reduction in severe maternal morbidity. Pregnancy Hypertens. 2018;14:55-58.

6. American College of Obstetricians and Gynecologists. Task force on hypertension in pregnancy. Hypertension in pregnancy. Obstet Gynecol. 2013;122:1122-1131.

7. Sibai BM. Diagnosis and management of gestational hypertension and preeclampsia. Obstet Gynecol. 2003;102:181-192.

8. Dean C, DouglasM J. Magnesium and the obstetric anaesthetist. Int J Obstet Anesth. 2013;22:255-256.

9. Askie LM, Duley L, Henderson-Smart DJ, Stewart LA; Paris Collaborative Group. Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data. Lancet. 2007;369:1765-1766.

10. LeFevre ML; Preventative Services Task Force. Low-dose aspirin use for the prevention of morbidity and mortality from preeclampsia: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2014;161:819-826.

11. Lisonkova S, Joseph KS. Incidence of preeclampsia: risk factors and outcomes associated with early- versus late-onset disease. AJOG. 2013;209:544.e1-544.e12.

12. Valensise H, et al. Early and late preeclampsia: two different maternal hemodynamic states in the latent phase of the disease. Hypertension. 2008;52:873-880.

13. Koopmans CM, et al. Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia after 36 weeks’ gestation (HYPITAT): a multicentre, open-label randomised controlled trial. Lancet. 2009;374:979-988.

14. Broekhuijsen K, et al, Immediate delivery versus expectant monitoring for hypertensive disorders of pregnancy between 34 and 37 weeks of gestation (HYPITAT-II): an open-label, randomised controlled trial. Lancet. 2015;385:2492–501.

15. Grobman WA, et al. Labor induction versus expectant management in low-risk nulliparous women. N Engl J Med. 2018;379:513-523.

16. McDermott M, et al. Preeclampsia association with posterior reversible encephalopathy syndrome and stroke. Stroke. 2018;49:524-530.

17. Martin JN, et al. Stroke and severe preeclampsia and eclampsia: a paradigm shift focusing on systolic blood pressure. Obstet Gynecol. 2005;105:246-254.

18. Bernstein PS, et al. National partnership for maternal safety consensus bundle on severe hypertension during pregnancy and the postpartum period. Obstetrics and Gynecology. 2017;130.

19. Levy N, et al. Neuraxial block for delivery among women with low platelet counts: a retrospective analysis. Int J Obstet Anesth. 2018;35:4-9.13.

20. Aya AG, et al. Spinal anesthesia-induced hypotension: a risk comparison between patients with severe preeclampsia and healthy women undergoing preterm cesarean delivery. Anesth Analg. 2005;101:869-875.

21. Visalyaputra S, et al. Spinal versus epidural anesthesia for cesarean delivery in severe preeclampsia: a prospective randomized, multicenter study. Anesth Analg. 2005 Sep;101:862-868.

22. Loureiro L, et al. Diffusion imaging may predict reversible brain lesions in eclampsia and severe preeclampsia: initial experience. Am J Obstet Gynecol. 2003;189:1350-1355.

23. Pant M, Fong R, Scavone B. Prevention of peri-induction hypertension in preeclamptic patients: a focused review. Anesth Analg. 2014;119:1350-1356.

24. Bokslag A, Teunissen PW, Franssen C, et al. Effect of early-onset preeclampsia on cardiovascular risk in the fifth decade of life. Am J Obstet Gynecol. 2017;216:523.e1-7.